Growth Metrics

Ironwood Pharmaceuticals (IRWD) Cash from Investing Activities (2016 - 2025)

Ironwood Pharmaceuticals' Cash from Investing Activities history spans 16 years, with the latest figure at $1000.0 for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities changed N/A to $1000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$34000.0, a 76.06% increase, with the full-year FY2025 number at -$34000.0, up 76.06% from a year prior.
  • Cash from Investing Activities hit $1000.0 in Q4 2025 for Ironwood Pharmaceuticals, up from -$2000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for IRWD hit a ceiling of $27000.0 in Q4 2022 and a floor of -$999.5 million in Q2 2023.
  • Historically, Cash from Investing Activities has averaged -$64.2 million across 5 years, with a median of -$44500.0 in 2024.
  • Biggest five-year swings in Cash from Investing Activities: soared 121.09% in 2022 and later plummeted 1135686.36% in 2023.
  • Tracing IRWD's Cash from Investing Activities over 5 years: stood at -$128000.0 in 2021, then soared by 121.09% to $27000.0 in 2022, then tumbled by 15611.11% to -$4.2 million in 2023, then skyrocketed by 99.62% to -$16000.0 in 2024, then skyrocketed by 106.25% to $1000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for IRWD at $1000.0 in Q4 2025, -$2000.0 in Q3 2025, and -$2000.0 in Q2 2025.